🇺🇸 FDA
Patent

US 10842814

Use of low dose arsenic for preserving genomic integrity

granted A61KA61K33/36A61K9/0019

Quick answer

US patent 10842814 (Use of low dose arsenic for preserving genomic integrity) held by The Board of Regents of the University of Texas System expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K33/36, A61K9/0019, A61P, A61P35/00